Get startedLog in
    Picture of Elevation Oncology logo

    ELEV — Elevation Oncology News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapValue Trap
    All News

    Brief: Elevation Oncology Expands Ongoing Phase 1 Clinical Trial Of EO-3021 Globally, Dosing First Patient In Japan

    Picture of Elevation Oncology logoElevation Oncology
    22/02/2024 14:40
    Feb 22 (Reuters) - Elevation Oncology Inc  ELEV.O :
    * ELEVATION ONCOLOGY EXPANDS ONGOING PHASE 1 CLINICAL TRIAL
OF
EO-3021 GLOBALLY, DOSING FIRST PATIENT IN JAPAN
    * ELEVATION ONCOLOGY INC - ON TRACK TO PROVIDE UPDATE FROM
ONGOING
PHASE 1 CLINICAL TRIAL IN MID-2024; ADDITIONAL DATA EXPECTED IN
1H 2025

Source text for Eikon:  ID:nPn4zkKm0a 
Further company coverage:  ELEV.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Elevation Oncology

    See all news